...
首页> 外文期刊>BMC Gastroenterology >Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study
【24h】

Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study

机译:肝硬化的发病率,病毒学和相关司法性:基于瑞典人群的队列研究

获取原文
           

摘要

The incidence of cirrhosis for individuals in Sweden has previously been reported as stable/low among European countries. However, Swedish population-based studies are scarce and none of them included data from the most recent decade (2010–2019). We aimed to describe the incidence and aetiology of cirrhosis in the Halland region from 2011 to 2018, and to describe the severity and prevalence of liver-related complications and other primary comorbidities at the time of cirrhosis diagnosis. We conducted a retrospective cohort study of all patients with cirrhosis in Halland, which has a population of 310,000 inhabitants. Medical records and histopathology registries were reviewed. A total of 598 patients with cirrhosis were identified. The age-standardised incidence was estimated at 23.2 per 100,000 person-years (95% CI 21.3–25.1), 30.5 (95% CI 27.5–33.8) for men and 16.4 (95% CI 14.3–18.7) for women. When stratified by age, the highest incidence rates were registered at age 60–69?years. Men had a higher incidence rate for most age groups when compared to women. The most common aetiology was alcohol (50.5%), followed by cryptogenic cirrhosis (14.5%), hepatitis C (13.4%), and non-alcoholic fatty liver disease (5.7%). Most patients had at least one liver-related complication at diagnosis (68%). The most common comorbidities at diagnosis were arterial hypertension (33%), type 2 diabetes (29%) and obesity (24%). Based on previous Swedish studies, our results indicate that the incidence of cirrhosis in Sweden might be considerably higher than previously reported. It is uncertain if the incidence of cirrhosis has previously been underestimated or if an actual increment has occurred during the course of the most recent decade. The increased incidence rates of cirrhosis reported in Halland are multifactorial and most likely related to higher incidence rates among the elderly. Pre-obesity and obesity are common in cirrhosis and non-alcoholic fatty liver disease has become an important cause of cirrhosis in Halland.
机译:瑞典个人的肝硬化发病率先报告为欧洲国家的稳定/低。然而,瑞典人口的研究是稀缺的,它们都没有包括来自最近十年(2010-2019)的数据。我们的目标是从2011年到2018年描述Halland地区肝硬化的发病率和抑制,并描述肝硬化诊断时肝相关并发症和其他主要合并症的严重程度和患病率。我们对Halland中的所有肝硬化患者进行了回顾性队列研究,该患者具有310,000名居民的人口。审查了医疗记录和组织病理学注册管理机构。共发现了598例肝硬化患者。年龄标准化发病率估计为每10万人 - 年(95%CI 21.3-25.1),30.5(95%CI 27.5-33.8),女性和16.4(95%CI 14.3-18.7)。当按年龄分层时,最高的发病率在60-69岁时注册?年。与女性相比,男性对大多数年龄组的发病率较高。最常见的病毒学是醇(50.5%),其次是密码肝硬化(14.5%),丙型肝炎(13.4%)和非酒精脂肪肝病(5.7%)。大多数患者在诊断(68%)中至少存在一个肝相关的并发症。诊断中最常见的合并症是动脉高血压(33%),2型糖尿病(29%)和肥胖(24%)。基于以前的瑞典研究,我们的结果表明,瑞典肝硬化的发病率可能比以前报道的高度高。它是不确定的肝硬化的发生率是否先前被低估或在最近十年的过程中发生实际增量。哈兰报道的肝硬化发病率增加是多因素,最可能与老年人的发病率较高。肥胖症和肥胖在肝硬化中常见,非酒精性脂肪肝病已成为Halland肝硬化的重要原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号